START Center for Cancer Care to Open New Locations in Lisbon and Dublin
Retrieved on:
Tuesday, November 15, 2022
University, Education, Health, Pharmaceutical, Oncology, Training, Research, Hospitals, Science, Clinical Trials, Continuing, FDA, Mater Misericordiae University Hospital, Mater, CHLN, Hospital de São José, Cancer, Research, Instituto de Medicina Molecular, START, Mater Hospital Pimlico, Hospital de Santa Maria, Sister, Union, Faculdade de Medicina da Universidade Federal de Minas Gerais, University College Dublin, The Sisters of Mercy, Hospital, Patient, Pharmaceutical industry, Medicine
The START Center for Cancer Care , a San Antonio-based oncology early-phase clinical research site network, will open Portugals first facility in Lisbon in late 2022 and is slated to open Irelands first early-phase clinical research facility in Dublin in early 2023.
Key Points:
- The START Center for Cancer Care , a San Antonio-based oncology early-phase clinical research site network, will open Portugals first facility in Lisbon in late 2022 and is slated to open Irelands first early-phase clinical research facility in Dublin in early 2023.
- For Lisbon, the principal investigator had previously trained at the START training program in START Madrid.
- START Center operates six existing locations across the U.S. and Spain, which makes it one of the largest early-phase clinical research sites in the world.
- The dedication to finding and developing the best cancer treatments drives each of us, START Center President and Founder Lon S. Smith, M.D.